CRT 2024
Symposium
POWER BREAK SYMPOSIUM – Changing the Paradigm for Pulmonary Embolism Treatment and ACS Thrombus Management [Non-CME] – Sponsored by Penumbra, Inc.
S. Jay Mathews, MD
Director, Cardiac Cath Lab, PERT, & Structural Heart
Manatee Memorial Hospital
Disclosure(s): Abbott: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Akura Medical: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Bolt Medical: Consultant/Advisory Board (Ongoing); Boston Scientific: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Cardiva: Consultant (Ongoing), Speakers' Bureau (Ongoing); CONTEGO MEDICAL: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Cordis, Endovascular Division: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Endologix: Consultant (Ongoing); Evident Vascular: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Innova vascular: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Inquis: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speakers' Bureau (Ongoing); Philips Medical: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speakers' Bureau (Ongoing); Protexa: Advisory Committee/Board Member (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Reflow Medical: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Shockwave: Consultant (Ongoing), Speakers' Bureau (Ongoing)